Food Retention at Endoscopy Among Adults Using Glucagon-Like Peptide-1 Receptor Agonists
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.36783
Abstract: This cross-sectional study investigates the association between glucagon-like peptide-1 receptor agonists and food retention during esophagogastroduodenoscopy. read more here.
Keywords: food retention; like peptide; receptor agonists; peptide receptor ... See more keywords
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.26321
Abstract: This cohort study examines the occurrence of diabetic retinopathy, ischemic optic nerve disease, or other ocular complications within 2 years of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among patients with type 2 diabetes. read more here.
Keywords: patients type; receptor agonists; type diabetes; glp receptor ... See more keywords
GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2025.2536
Abstract: This Viewpoint discusses the use of glucagon-like peptide-1 (GLP-1) receptor agonists as a strategy to manage psychotropic-induced weight gain. read more here.
Keywords: glp receptor; receptor agonists; weight gain; induced weight ... See more keywords
Design, synthesis, and structure–activity relationships of diindolylmethane derivatives as cannabinoid CB2 receptor agonists
Sign Up to like & getrecommendations! Published in 2022 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202200493
Abstract: 3,3′‐Diindolylmethane (DIM), a natural product‐derived compound formed upon ingestion of cruciferous vegetables, was recently described to act as a partial agonist of the anti‐inflammatory cannabinoid (CB) receptor subtype CB2. In the present study, we synthesized… read more here.
Keywords: receptor agonists; design synthesis; cb2 receptor; efficacy ... See more keywords
Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.70058
Abstract: Type 2 diabetes mellitus (T2DM) is recognized for increasing the risk of dementia; however, conclusive evidence supporting interventions to mitigate this risk remains elusive. This study endeavours to ascertain whether the glucagon‐like peptide‐1 receptor agonists… read more here.
Keywords: like peptide; diabetes mellitus; type diabetes; receptor agonists ... See more keywords
Synthetic cannabinoid receptor agonists and their human metabolites in sewage water: Stability assessment and identification of transformation products.
Sign Up to like & getrecommendations! Published in 2021 at "Drug testing and analysis"
DOI: 10.1002/dta.3129
Abstract: Since their first appearance in 2008, synthetic cannabinoid receptor agonists (SCRAs) remain the most popular new psychoactive substances (NPS) in the EU. Following consumption, these drugs and their metabolites are urinary excreted and enter the… read more here.
Keywords: sewage water; synthetic cannabinoid; receptor agonists; cannabinoid receptor ... See more keywords
Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists
Sign Up to like & getrecommendations! Published in 2025 at "ESC Heart Failure"
DOI: 10.1002/ehf2.15308
Abstract: Data support favourable haemodynamic benefits of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) on improving cardiac structural abnormalities and function in patients with heart failure (HF). However, the direct haemodynamic effects of GLP‐1 RAs remain inadequately… read more here.
Keywords: heart; receptor agonists; pulmonary artery; artery pressure ... See more keywords
Effect of the α2‐receptor agonists medetomidine, detomidine, xylazine, and romifidine on the ketamine metabolism in equines assessed with enantioselective capillary electrophoresis
Sign Up to like & getrecommendations! Published in 2017 at "ELECTROPHORESIS"
DOI: 10.1002/elps.201700017
Abstract: The combination of ketamine and an α2‐receptor agonist is often used in veterinary medicine. Four different α2‐receptor agonists, medetomidine, detomidine, xylazine, and romifidine, which differ in their chemical structure and thus in selectivity for the… read more here.
Keywords: receptor; xylazine romifidine; receptor agonists; agonists medetomidine ... See more keywords
GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection.
Sign Up to like & getrecommendations! Published in 2020 at "Advances in experimental medicine and biology"
DOI: 10.1007/5584_2020_494
Abstract: The risk of cardiovascular disease (CVD) (myocardial infarction, stroke, peripheral vascular disease) is twice in type 2 diabetes (T2D) patients compared to non-diabetic subjects. Furthermore, cardiovascular disease (CV) is the leading cause of death in… read more here.
Keywords: type diabetes; treatment; receptor agonists; cardiovascular protection ... See more keywords
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
Sign Up to like & getrecommendations! Published in 2021 at "Diabetologia"
DOI: 10.1007/s00125-021-05508-1
Abstract: Concerns have been raised regarding a potential association of use of the incretin-based drugs dipeptidyl peptidase 4 (DPP4) inhibitors and glucagon-like peptide-1 (GLP-1)-receptor agonists with risk of cholangiocarcinoma. We examined this association in nationwide data… read more here.
Keywords: dpp4 inhibitors; receptor agonists; cholangiocarcinoma; glp receptor ... See more keywords
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Sign Up to like & getrecommendations! Published in 2024 at "Acta Diabetologica"
DOI: 10.1007/s00592-024-02300-6
Abstract: Type 2 diabetes represents a growing challenge for global public health. Its prevalence is increasing worldwide, and, like obesity, it affects progressively younger populations compared to the past, with potentially greater impact on chronic complications.… read more here.
Keywords: gip receptor; receptor agonists; type; type diabetes ... See more keywords